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Histamine Enhances the Production of Granulocyte-Macrophage
Colony-Stimulating Factor via Protein Kinase Ca and Extracellular
Signal-Regulated Kinase in Human Keratinocytes
Naoko Kanda and Shinichi Watanabe
Department of Dermatology, Teikyo University, School of Medicine, Tokyo, Japan
The production of granulocyte-macrophage colony-stimulating factor (GM-CSF) in keratinocytes is related to the
chronicity of atopic dermatitis. Mast cell-derived histamine contributes to the cross-talk between mast cells and
keratinocytes. We examined the effects of histamine on GM-CSF production in human keratinocytes. Histamine
increased GM-CSF secretion, mRNA stability and promoter activity. Activator protein-1 (AP-1) and nuclear factor-jB
(NF-jB) elements on the promoter were responsible for the activation by histamine. Histamine enhanced
transcriptional activity and DNA binding of AP-1 and NF-jB. Histamine shifted AP-1 composition form c-Jun
homodimers to c-Fos/c-Jun heterodimers, and transiently expressed c-Fos protein. Histamine rapidly induced the
phosphorylation and degradation of inhibitory jB. Histamine induced membrane translocation of protein kinase
Ca. Histamine-induced GM-CSF production was completely abolished by H1 antagonist pyrilamine and
conventional protein kinase C inhibitor Go¨6976, and partially suppressed by PD98059 which inhibits the activation
of extracellular signal-regulated kinase. Go¨6976 and PD98059 suppressed histamine-induced c-Fos expression and
AP-1 activation. Go¨6976 and PD98059 suppressed histamine-induced enhancement of NF-jB transcriptional
activity. Histamine-induced phosphorylation and degradation of inhibitory jB was suppressed by Go¨6976, but not
by PD98059. These results suggest that histamine may enhance GM-CSF production at transcriptional and
posttranscriptional levels via H1 receptor, protein kinase Ca and extracellular signal-regulated kinase.
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Granulocyte macrophage colony-stimulating factor (GM-
CSF) plays an important role in the development and
perpetuation of atopic dermatitis (Pastore et al, 1997). In the
skin lesions with atopic dermatitis, GM-CSF is overpro-
duced by keratinocytes (Pastore et al, 1997). GM-CSF
promotes the migration, survival, and antigen-presenting
capacity of epidermal Langerhans cells and dermal den-
dritic cells, and supports the differentiation into dendritic
cells from peripheral blood precursors (Pastore et al, 1997).
GM-CSF also promotes the survival of eosinophils and
monocyte/macrophages, and enhances the proliferation of
keratinocytes, contributing the perpetuation of inflammation
and epidermal hyperplasia in the chronic lesions with atopic
dermatitis (Braunstein et al, 1994; Bratton et al, 1995). In the
skin lesions with atopic dermatitis, mast cells are increased
in the dermis and may be involved in the development of
inflammation (Damsgaard et al, 1997; Ackermann and
Harvima, 1998). Activated mast cells release histamine,
and local histamine concentration is also increased in the
lesions with atopic dermatitis (DeMora et al, 1996). The
mast cell-derived histamine contributes to the cross-talk
between mast cells and keratinocytes. Histamine acts on
keratinocytes and promotes their production of adhesion
molecules like intercellular adhesion molecule-1 or of
proinflammatory cytokines or chemokines like interleukin
(IL)-6, IL-8 (Kohda et al, 2002), or nerve growth factor
(Kanda and Watanabe, 2003b). It is thus plausible that
histamine may also induce GM-CSF production in kerati-
nocytes. Previous study reported that histamine in vitro
enhanced GM-CSF production by human conjunctival
(Weimer et al, 1998), nasal (Terada et al, 1999), bronchial
(Takizawa et al, 1995), or tracheal epithelial cells (Churchill
et al, 1992). But it has not been examined if histamine may
enhance GM-CSF production by human epidermal kerati-
nocytes. Besides it is unknown which level of GM-CSF
production, i.e., translational or transcriptional, histamine
may potentiate. In addition, previous studies did not show
intracellular signaling events responsible for the GM-CSF
induction by histamine.
Histamine binds to cell surface receptors coupling to
guanine nucleotide-binding protein and induces various
intracellular signaling pathways. Four isotypes of histamine
receptors have been identified, H1, H2, H3, and H4
Abbreviations: ANOVA, analysis of variance; AP-1, activator
protein-1; ARE, AU-rich element; EMSA, electrophoretic mobility
shift assay; ERK, extracellular signal-regulated kinase; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; GM-CSF, granulo-
cyte-macrophage colony-stimulating factor; IkB, inhibitory kB;
MAPK, mitogen-activated protein kinase; MEK, MAPK kinase; NF-
AT, nuclear factor of activated T cells; NF-kB, nuclear factor-kB;
PKC, protein kinase C; PLC, phospholipase C
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receptors (Oda et al, 2000). H1 receptor is linked to the
activation of phospholipase C (PLC) which generates
diacylglycerol, activating protein kinase C (PKC) (Megson
et al, 2001). Stimulation of H2 receptor mostly activates
adenylate cyclase which generates cAMP signal; however,
H2 receptor is also linked to PLC in certain cell types (Del
Valle and Gantz, 1997). H3 and H4 receptors are coupled to
the inhibition of adenylate cyclase (Coge et al, 2001). These
histamine receptor-mediated signals regulate cytokine or
chemokine gene expression in target cells (Kanda and
Watanabe, 2002). We have recently found that histamine
binds to H1 receptor on human keratinocytes, and induces
PLC/PKC/mitogen-activated protein kinase (MAPK) kinase
1 (MEK1)/extracellular signal-regulated kinase (ERK) signal-
ing cascade (Kanda and Watanabe, 2003b).
In this study, we examined the effects of histamine on
GM-CSF production in cultured human keratinocytes. We
found that histamine enhanced GM-CSF production in
keratinocytes via H1 receptors at both transcriptional and
post-transcriptional levels. We further examined the precise
mechanism for these effects focusing on the histamine-
induced intracellular signaling pathways.
Results
Histamine enhanced GM-CSF secretion in keratinocy-
tes Keratinocytes constitutively secreted a low amount of
GM-CSF (mean  SEM 15.5  1.8 pg per mL, n¼5), and
the secretion was concentration dependently increased by
histamine; the stimulatory effect of histamine was mani-
fested at 0.1 mM, and was maximized at 1 mM which
increased the secretion 6.1-fold of controls (Fig 1). H1
receptor antagonist pyrilamine blocked the stimulatory
effect of histamine while H2 antagonist cimetidine or H3
and H4 antagonist thioperamide did not. These results
suggest that H1 receptor but not H2, H3, or H4 receptors
may mediate histamine-induced enhancement of GM-CSF
secretion in keratinocytes. Since 1 mM of histamine was
optimal for GM-CSF induction, this concentration will be
used in the following experiments.
As examined by ELISAs, constitutive histamine secretion
by keratinocytes was mean  SEM 9.55  0.91 nM (n¼ 5)
which was less than the threshold (100 nM) for GM-CSF
induction (Fig 1). Pyrilamine, cimetidine, and thioperamide
did not reduce the constitutive GM-CSF secretion in the
absence of exogenous histamine (data not shown). These
results suggest that endogenous histamine secreted by
keratinocytes may not contribute to GM-CSF secretion. We
next examined if histamine may increase steady-state GM-
CSF mRNA level in keratinocytes.
Histamine increased GM-CSF mRNA levels At 3 h of
incubation, histamine increased GM-CSF mRNA level 6.2-
fold of controls, which was blocked by pyrilamine but not
by cimetidine or thioperamide (Fig 2). Thus, histamine
increased GM-CSF production via H1 receptors at pre-
translational level. We then examined if histamine may
enhance GM-CSF mRNA stability.
Histamine stabilized GM-CSF mRNA Keratinocytes were
treated with actinomycin D after incubation with or without
histamine for 3 h, and the decay of GM-CSF mRNA was
chased (Fig 3). The estimated half-life of GM-CSF mRNA in
histamine-treated cells was mean  SEM 42.3  2.5 min
(n¼4), which was significantly higher than that in controls
(23.1  2.2 min, po0.05 by paired t test). The histamine-
induced increase of the half-life was blocked by pyrilamine
Figure1
Concentration dependency for the effects of histamine on
granulocyte-macrophage colony-stimulating factor (GM-CSF) se-
cretion and the inhibition by histamine receptor antagonists.
Keratinocytes were preincubated with pyrilamine, cimetidine, or
thioperamide (each 10 mM) for 30 min, then incubated with indicated
doses of histamine for 24 h in the presence of the antagonists. The
culture supernatants were assayed for GM-CSF. Values are mean  SD
of triplicate cultures. po0.05 versus control cultures, by one-way
ANOVA with Dunnett’s multiple comparison test. The data shown in the
figure are representative of five separate experiments.
Figure2
The effects of histamine on steady-state mRNA level of granulo-
cyte-macrophage colony-stimulating factor (GM-CSF) in keratino-
cytes. Keratinocytes were preincubated with pyrilamine (PR),
cimetidine (CM), or thioperamide (TP) (each 10 mM) for 30 min, then
incubated with 1 mM histamine (HA). After 3 h, RNA was isolated, and
RT-PCR was performed. The intensity of the band for GM-CSF was
corrected to that for glyceralehyde-3-phosphate dehydrogenase
(GAPDH). The lower graph shows the corrected intensities relative to
that in control cells cultured with medium alone (set as 1.0). The results
shown in the figure are representative of five separate experiments.
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but not by cimetidine or thioperamide. These results
indicate that histamine may stabilize GM-CSF mRNA via
H1 receptors.
Histamine enhanced GM-CSF promoter activity We then
examined if histamine may enhance GM-CSF transcription
in keratinocytes. It is reported that human GM-CSF gene
contained cis-elements homologous to NF-kB, AP-1, and
nuclear factor of activated T cells (NF-AT) sites (Fig 4a), and
these may act as enhancer elements for GM-CSF transcrip-
tion (Tsuboi et al, 1994; Jenkins et al, 1995; Pastore et al,
2000). We transiently transfected GM-CSF promoter (620/
þ37 bp) linked to luciferase reporter into human keratino-
cytes. Histamine treatment increased wild-type GM-CSF
promoter activity 3.1-fold of controls, and the effect was
blocked by pyrilamine (Fig 4b, first three columns). Thus
histamine appeared to enhance GM-CSF transcription in
addition to mRNA stabilization. The mutation of AP-1-like
element reduced the basal promoter activity and completely
abrogated histamine-induced enhancement of the promoter
activity (Fig 4b, third three columns). The mutation of NF-
kB-like element reduced basal promoter activity and the
fold-increase by histamine; however, the stimulatory effect
of histamine still remained (Fig 4b, second three columns).
The mutation of both NF-kB- and AP-1-like elements
completely abrogated the basal and histamine-induced
promoter activities (Fig 4b, fourth three columns). On the
other hand, the mutation of NF-AT-like element did not
affect either basal or histamine-induced promoter activities
(Fig 4b, last three columns), indicating that this element may
be dispensable for basal and histamine-induced GM-CSF
transcription. These results suggest that basal and hista-
mine-induced GM-CSF transcription may be dependent on
AP-1- and NF-kB-like elements, and the contribution of the
former may be higher. We then analyzed if histamine may
enhance transactivation capacities through AP-1- or NF-
kB-like elements.
Histamine enhanced transcription from AP-1- and NF-
jB-like elements Keratinocytes were transiently trans-
fected with luciferase reporter linked to four repeats of
NF-kB- or AP-1-like elements in front of TATA box.
Histamine potently enhanced transcription through AP-1-
like element (4.5-fold of controls), and modestly increased
that through NF-kB-like element (2.3-fold) (Fig 5). These
effects of histamine were counteracted by pyrilamine,
indicating the involvement of H1 receptors.
Histamine induced c-Fos/c-Jun binding to AP-1 site by
transient induction of c-Fos We then examined if hista-
mine may enhance DNA binding of transcription factors
at AP-1-like site on GM-CSF promoter in parallel with the
transactivation capacity. At 1 h of incubation, histamine
increased the amount of DNA–protein complex with AP-1-
containing probe, and the effect was counteracted by
pyrilamine (Fig 6a, lanes 2–4). These results suggest that
histamine may promote transcription factor binding to AP-
1-like site via H1 receptors. In unstimulated keratinocytes,
anti-c-Jun did but anti-c-Fos antibody did not supershift
the complex (Fig 6a, lanes 5, 6) whereas in histamine-
stimulated keratinocytes, both antibodies supershifted the
complex (Fig 6a, lanes 7 and 8). Antibodies against the
other Fos family (FosB, Fra-1, Fra-2) or Jun family (JunB,
JunD) proteins did not supershift the complexes by nuclear
extracts from unstimulated or histamine-stimulated kerati-
nocytes (data not shown). These results suggest that
histamine may shift the AP-1 composition from c-Jun
homodimers to c-Fos/c-Jun heterodimers. We then exam-
ined if histamine may increase c-Fos or c-Jun protein levels
in keratinocytes. Histamine rapidly and transiently induced
c-Fos protein; in unstimulated cells, c-Fos was undetect-
able, however, after stimulation with histamine, c-Fos was
induced at 30 min, then reduced at 1 h, and disappeared at
90 min (Fig 6b). c-Jun protein was constitutively detectable
and was not increased by histamine. The results indicate
that histamine-induced activation of AP-1 may be mainly
attributable to the rapid and transient induction of c-Fos.
Histamine enhanced DNA binding of NF-jB p50/p65 by
phosphorylation and degdradation of IjBa We next
examined if histamine may enhance DNA binding of
NF-kB as well as AP-1. At 1 h of incubation, histamine
increased the amount of DNA–protein complex with NF-kB-
containing probe, and the effect was blocked by pyrilamine
(Fig 7a, lanes 2–4). Supershift assays showed that the
NF-kB complex was composed of p50 and p65 both in
unstimulated and histamine-stimulated cells (Fig 7a, lanes
5–8), whereas antibody against c-Rel did not supershift the
complex (data not shown). Thus, histamine enhanced DNA
binding of NF-kB p50/p65 heterodimers. In resting state,
NF-kB p50/p65 dimers are sequestered in cytoplasm and
are complexed with inhibitory protein, IkBa. Upon stimula-
tion, IkBa is phosphorylated and released from the
complex, and ubiquitinated and degradated by protea-
some, which releases NF-kB to undergo nuclear transloca-
tion and binding to consensus elements on target genes
Figure 3
The effects of histamine on granulocyte-macrophage colony-
stimulating factor (GM-CSF) mRNA stability. Keratinocytes were
preincubated with pyrilamine (PR), cimetidine (CM), or thioperamide
(TP) (each 10 mM) for 30 min, then incubated with 1 mM histamine (HA)
for another 3 h. Actinomycin D (5 mg per mL) was then added and RNA
was isolated 0, 30, 60, and 90 min later, and RT-PCR was performed.
The ratio of GM-CSF/glyceralehyde-3-phosphate dehydrogenase
(GAPDH) mRNA band density was normalized to that at 0 min (set as
100%). The data are mean  SEM of four separate experiments. Half-
life of GM-CSF mRNA is noted for each condition.
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(Lallena et al, 1999). We thus analyzed if histamine may
induce the phosphorylation and degradation of IkBa,
necessary for DNA binding of NF-kB. At 10 min of histamine
incubation, phosphorylation of IkBa was detected (Fig 7b,
upper panel, lane 2), which was also confirmed by slower
migrating form of IkBa (Fig 7b, lower panel, lane 2), and at
30 min, the amount of IkBa was reduced (Fig 7b, lower
panel, lane 3), indicating histamine-induced degradation of
IkBa. At 60 min, IkBa returned to the basal level (Fig 7b,
lower panel, lane 4), indicating the re-synthesis of IkBa.
These results indicate that histamine may enhance DNA
binding of NF-kB p50/p65 heterodimers via phosphoryla-
tion and degradation of IkBa.
PKCa and ERK were involved in histamine-induced GM-
CSF production We have recently found that histamine
binds to H1 receptor on keratinocytes, and induces
membrane translocation of PKC activity dependently on
PLC. The histamine-induced activation of PKC also led to
the activation of downstream kinases, MEK1 and ERK
(Kanda and Watanabe, 2003b). PKC isoforms are classified
into Ca2þ and diacylglycerol-dependent conventional iso-
forms (PKCa, bI, bII, g), Ca2þ -independent and diacylgly-
cerol-dependent novel isoforms (PKCd, e, m, y, and Z), and
Ca2þ and diacylglycerol-independent atypical isoforms
(PKCz, l/t) (Reynolds et al, 1994). To date, PKCa, d, e, Z,
and z have been detected in keratinocytes (Reynolds et al,
1994). We thus analyzed which PKC isoforms may be
translocated from cytosol to membrane by histamine. In
resting keratinocytes, conventional PKCa and novel PKCd
are expressed abundantly in cytosol and to lesser amounts
in membrane (Fig 8). Histamine induced membrane trans-
location of PKCa, but not that of PKCd. The histamine-
Figure 4
The effects of histamine on the activ-
ities of wild-type or mutated granulo-
cyte-macrophage colony-stimulating
factor (GM-CSF) promoters. (a) Sche-
matic representation of human GM-CSF
promoter. The locations of cis-elements
are shown with their sequences, and
substituted bases for mutation are indi-
cated. The nucleotide positions are rela-
tive to the transcriptional start site. (b)
Keratinocytes were transiently trans-
fected with wild-type (WT) or mutated
pGM-CSF luc together with thymidine
kinase promoter-linked renilla luciferase
vector (pRL-TK). The cells were preincu-
bated with or without 10 mM pyrilamine
(PR) for 30 min, then treated with 1 mM
histamine (HA). After 6 h, firefly and renilla
luciferase activities were analyzed. The
data shown as firefly: renilla luciferase
ratios are mean  SEM of four separate
experiments. Values at right indicate the
fold induction versus basal promoter
activity. , po0.05 versus control values,
w, po0.05 versus values with histamine
alone, by one-way ANOVA with Scheffe’s
multiple comparison test.
Figure 5
The effects of histamine on nuclear factor-jB (NF-jB) or activator
protein-1 (AP-1) transcriptional activities. Keratinocytes were tran-
siently transfected with p4xNF-kB or AP-1-TATA-luc or enhancerless
pTATA-luc, together with thymidine kinase promoter-linked renilla
luciferase vector (pRL-TK). The cells were preincubated with 10 mM
pyrilamine (PR) for 30 min, then incubated with 1 mM histamine (HA).
After 6 h, firefly and renilla luciferase activities were analyzed. The
results represent mean  SEM of four separate experiments. Values at
right indicate the fold induction versus basal activity. , po0.05 versus
control values, w, po0.05 versus values with histamine alone, by one-
way ANOVA with Scheffe’s multiple comparison test.
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induced membrane translocation of PKCa was blocked by
pyrilamine. Much smaller amounts of novel PKCe, Z, and
atypical PKCz were detected only in cytosolic fraction of
keratinocytes, and histamine did not induce the membrane
translocation of these isoforms. Thus, histamine appeared
to selectively activate conventional PKCa via H1 receptors
in keratinocytes.
We then analyzed if PKCa and downstream kinase ERK
may be responsible for histamine-induced GM-CSF ex-
pression using specific kinase inhibitors. The concentration
of each inhibitor was determined from reported IC50 values
(Li et al, 2002). Conventional and novel PKC inhibitor
GF109203X and conventional PKC inhibitor Go¨6976 com-
pletely blocked histamine-induced enhancement of GM-
CSF secretion (Fig 9a), promoter activity (Fig 9b), and mRNA
stability (Fig 9c, data not shown for GF109203X). These
were partially suppressed by MEK1 inhibitor PD98059,
which inhibits the activation of ERK. On the other hand,
novel PKC inhibitor rottlerin, p38 MAPK inhibitor
SB203580,or c-Jun N-terminal kinase inhibitor SP600125
did not affect histamine-induced GM-CSF secretion, pro-
moter activation, or mRNA stabilization. These results
suggest the requirement of PKCa and ERK for histamine-
induced enhancement of GM-CSF production both at
transcriptional and post-transcriptional levels.
In parallel with GM-CSF transcription, histamine-induced
increase of AP-1 transcriptional activity was blocked by
Go¨6976 (Fig 10a), GF109203X (data not shown), and
PD98059 (Fig 10a) although these were not altered by
rottlerin, SB203580, or SP600125 (data not shown). Go¨6976
and PD98059 also suppressed the enhancement of DNA
binding of AP-1 (Fig 10b) and c-Fos induction by histamine
(Fig 10c). These results suggest that PKCa and ERK may be
required for histamine-induced c-Fos expression and
resultant activation of AP-1.
As with AP-1, histamine-induced increase of NF-kB
transcriptional activity was suppressed completely by
Figure 6
The effects of histamine on DNA binding of activator protein-1
(AP-1) and on c-Fos or c-Jun protein levels. (a) Keratinocytes were
preincubated with 10 mM pyrilamine (PR) for 30 min, then incubated
with 1 mM histamine (HA) for 1 h. Nuclear extracts were prepared, and
incubated with AP-1-containing probe. In supershift assays, nuclear
extracts were incubated with antibodies against c-Fos or c-Jun for
30 min before the addition of the probe. The asterisks indicate the
supershifted complexes. (b) Keratinocytes were incubated with 1 mM
histamine. At indicated time points, whole-cell extracts were isolated,
and the expression of c-Fos or c-Jun was analyzed by western blotting.
The results shown in the figure are representative of five separate
experiments.
Figure7
The effects of histamine on DNA binding of NF-jB and on
phosphorylation or degradation of IjBa. (a) Keratinocytes were
preincubated with 10 mM pyrilamine (PR) for 30 min, then incubated
with 1 mM histamine (HA) for 1 h. Nuclear extracts were prepared, and
incubated with NF-kB-containing probe. In supershift assays, nuclear
extracts were incubated with antibodies against NF-kB p50 or p65 for
30 min before the addition of the probe. The asterisks indicate the
supershifted complexes. (b) Keratinocytes were incubated with 1 mM
histamine. At indicated time points, whole-cell extracts were isolated,
and the levels of phosphorylated or total IkBa were analyzed by
western blotting. The results shown in the figure are representative of
five separate experiments.
Figure8
The histamine-induced membrane translocation of protein kinase
C (PKC) isoforms. Keratinocytes were preincubated with 10 mM
pyrilamine (PR) for 30 min, then incubated with 1 mM histamine (HA) for
5 min. Cytosolic and membrane fractions were isolated from whole-cell
extracts, and the levels of PKC isoforms in each fraction were analyzed.
The results shown in the figure are representative of five separate
experiments.
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Go¨6976 (Fig 11a) and GF109203X (data not shown) and
partially by PD98059 (Fig 11a), but not by rottlerin,
SB203580, or SP600125 (data not shown). These results
suggest that histamine-stimulated PKCa and ERK may
enhance transcriptional activities of AP-1 and NF-kB, and
thus promote GM-CSF transcription dependent on AP-1
and NF-kB. Go¨6976 suppressed histamine-induced en-
hancement of DNA binding of NF-kB (Fig 11b), and
histamine-induced IkBa phosphorylation and degradation
(Fig 11c) while these were not suppressed by PD98059.
These results indicate that histamine-activated PKCa may
promote IkBa phosphorylation and degradation and resul-
tantly enhance DNA binding of NF-kB and ERK may
enhance transcriptional activity of NF-kB by IkBa-indepen-
dent mechanism.
Discussion
Histamine enhanced GM-CSF production in human neona-
tal foreskin keratinocytes at transcriptional and post-
transcriptional levels via H1 receptors. We also preliminarily
found that histamine similarly increased GM-CSF secretion
and mRNA level in keratinocytes from lesional skin of atopic
dermatitis (data not shown). Histamine enhanced GM-CSF
transcription via the activation of AP-1 and NF-kB and also
stabilized GM-CSF mRNA. PKCa and downstream kinase
ERK are responsible for both transcriptional and post-
transcriptional effects. It is known that PKCa activates
c-Raf1, which phosphorylates and activates MEK1,
upstream kinase of ERK (Scho¨nwasser et al, 1998). In
keratinocytes, histamine may thus bind to H1 receptor and
possibly trigger PLC/PKCa/c-Raf1/MEK1/ERK signaling
cascade. PKCa inhibitor Go¨6976 completely blocked
histamine-induced GM-CSF production while the inhibitory
effect of MEK1 inhibitor PD98059 was partial, indicating that
PKCa may promote GM-CSF production by ERK-depen-
dent and -independent mechanisms. Among five PKC
isoforms a, d, e, Z, and z, PKCa, d, e, and Z can be
activated by diacylglycerol generated by PLC linked to H1
receptor; however, only PKCa appeared to be activated by
histamine. The results are consistent with those in H1
receptor-transfected Chinese hamster ovary cells (Megson
et al, 2001). Possibly, PKCd, e, and Z may not respond to
histamine-induced diacylglycerol due to their lower levels of
expression or tight compartmentalization in cytoplasm, or
both. It is also reported that individual PKC isoforms can be
activated dependently on stimuli added or cell types
(Reynolds et al, 1994; Li et al, 2002).
GM-CSF transcription in keratinocytes was more highly
dependent on AP-1 than on NF-kB; however, the coopera-
tion between AP-1 and NF-kB was required for sufficient
transcription (Fig 4b). Possibly AP-1 and NF-kB bound to
cis-elements on GM-CSF promoter may interact directly or
Figure9
The inhibition by protein kinase C (PKC) or
mitogen-activated protein kinase (MAPK)
inhibitors on histamine-induced granulo-
cyte-macrophage colony-stimulating factor
(GM-CSF) secretion (a), promoter activation
(b), and mRNA stabilization (c). (a) Keratino-
cytes were preincubated with 0.5 mM
GF109203X, 10 nM Go¨6976, 10 mM rottlerin,
10 mM PD98059, 10 mM SB203580, or 10 mM
SP600125 for 30 min, then incubated with 1 mM
histamine (HA). Culture supernatants were
harvested after 24 h. (b) Keratinocytes were
transiently transfected with pGM-CSF luc to-
gether with thymidine kinase promoter-linked
renilla luciferase vector (pRL-TK), then preincu-
bated with inhibitors and incubated with hista-
mine as above. After 6 h, firefly and renilla
luciferase activities were analyzed. (c) Kerati-
nocytes were preincubated with inhibitors and
then incubated with histamine as above. After 3
h, actinomycin D (5 mg per mL) was added, and
GM-CSF mRNA decay was chased 0, 30, 60,
and 90 min later. The data are mean  SEM of
five separate experiments. , po0.05 versus
control values, w, po0.05 versus values with
histamine alone, by one-way ANOVA with
Scheffe’s multiple comparison test. In (c), half-
life of GM-CSF mRNA is shown for each
culture.
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through common co-activators like CBP. Such physical
interaction may stabilize the DNA binding of each factor or
enhance the interaction of each factor with general
transcriptional apparatus like TATA-binding protein (Thomas
et al, 1997).
Histamine transiently induced c-Fos protein. The induced
c-Fos may heterodimerize with c-Jun and the heterodimers
may bind to AP-1-like site on GM-CSF promoter and drive
transcription. On the other hand, c-Jun homodimers
appeared to bind to AP-1-like site in unstimulated kerati-
nocytes. It is reported that c-Fos/c-Jun heterodimers much
more avidly bind to DNA and have much higher transcrip-
tional activity than c-Jun homodimers (Allegretto et al, 1990;
Suzuki et al, 1991). Thus, histamine may enhance DNA
binding and transcriptional activity of AP-1 by inducing
c-Fos and thus shifting AP-1 composition from c-Jun
homodimers to c-Fos/c-Jun heterodimers. This effect of
histamine also occurred in nerve growth factor gene
transcription dependent on AP-1 (Kanda and Watanabe,
2003b). PKCa and downstream kinase ERK were required
for the c-Fos induction by histamine, which is also reported
in H1 receptor-transfected Chinese hamster ovary cells
(Megson et al, 2001). c-fos promoter contains serum
response element where ternary complex factors like Elk1
or SAP1 are binding (Janknecht et al, 1995; Soh et al, 1999).
It is known that ERK-mediated phosphorylation of ternary
complex factor promotes its transcriptional activity (Marais
et al, 1993). It is thus anticipated that the phosphorylation of
ternary complex factors by ERK may be involved in
histamine-induced c-Fos expression.
Histamine enhanced transcriptional activity of NF-kB
though the magnitude of the enhancement was lower than
that of AP-1 (Fig 5). The histamine-induced activation of NF-
kB was at least partially mediated by the PKCa-dependent
phosphorylation and degradation of IkBa. It is reported that
PKCa can in vitro associate and activate IkB kinase b which
phosphorylates IkBa (Lallena et al, 1999). The activation of
IkB kinase b may be mediated by phosphorylation via PKCa
or downstream kinases (Lallena et al, 1999). Thus, in
histamine-stimulated keratinocytes, possible activation of
IkB kinase b by PKCa may induce the nuclear translocation
and DNA binding of NF-kB. Although the inhibition of ERK
partially suppresses histamine-induced increase of NF-kB
transcriptional activity, that did not suppress IkBa degrada-
tion and DNA binding of NF-kB (Fig 11). This indicates that
Figure 10
The inhibition by protein kinase Ca (PKCa) or ERK inhibitors on
histamine-induced activator protein-1 (AP-1) transcriptional activ-
ity (a), DNA binding (b), and c-Fos expression (c). (a) Keratinocytes
were transiently transfected with p4xAP-1-TATA-luc together with
promoter-linked renilla luciferase vector (pRL-TK), then preincubated
with 10 nM Go¨6976 or 10 mM PD98059 for 30 min, then incubated with
1 mM histamine (HA). After 6 h, firefly and renilla luciferase activities
were analyzed. The data are mean  SEM of five separate experi-
ments. , po0.05 versus control values, w, po0.05 versus values with
histamine alone, by one-way ANOVA with Scheffe’s multiple compar-
ison test. (b and c) Keratinocytes were preincubated with inhibitors, and
incubated with histamine as above. Electrophoretic mobility shift assay
(EMSA) was performed at 1 h (b) while c-Fos protein level was analyzed
at 30 min (c). The results shown in the figure are representative of five
separate experiments.
Figure11
The inhibition by protein kinase Ca (PKCa) or ERK inhibitors on
histamine-induced nuclear factor-jB (NF-jB) transcriptional activ-
ity (a), DNA binding (b), and phosphorylation or degradation of IjBa
(c). (a) Keratinocytes were transiently transfected with p4xNF-kB-TATA-
luc together with thymidine kinase promoter-linked renilla luciferase
vector (pRL-TK), then preincubated with 10 nM Go¨6976 or 10 mM
PD98059 for 30 min, then incubated with 1 mM histamine (HA). After 6 h,
firefly and renilla luciferase activities were analyzed. The data are
mean  SEM of five separate experiments. , po0.05 versus control
values, w, po0.05 versus values with histamine alone, by one-way
ANOVA with Scheffe’s multiple comparison test. (b and c) Keratino-
cytes were preincubated with inhibitors, then incubated with histamine
as above. electrophoretic mobility shift assay (EMSA) was performed at
1 h (b), phosphorylation of IB was analyzed at 10 min (c, upper panel),
and degradation of IB was analyzed at 30 min (c, lower panel). The
results shown in the figure are representative of five separate
experiments.
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ERK may IkBa-independently enhance transactivation
capacity of NF-kB. It is reported that ERK may phosphor-
ylate transactivation domain of NF-kB p65 directly or via
downstream kinases, and thus promotes its transcriptional
activity (Vanden Berghe et al, 1998). PKC is also known to
phosphorylate p65 and augment its transactivation poten-
tial (Schmitz et al, 1995).
Histamine stabilized GM-CSF mRNA dependently on
PKCa and ERK. 30 untranslated region of GM-CSF mRNA
contains AU-rich elements (AREs), which target mRNA for
degradation by ribonucleases (Shaw and Kamen, 1986).
Stabilizer proteins like YB-1 bind to AREs and block
recognition by ribonucleases (Capowski et al, 2001).
Conversely, destabilizer proteins like AUF1 bind to AREs
and target ribonuclease activities (Buzby et al, 1996). The
activities of these ARE-binding proteins are regulated by
phosphorylation/dephosphorylation (Rajagopalan and Mal-
ter, 1994). Histamine may thus promote the binding of
stabilizers or reduce that of destabilizers, or both, by
phosphorylation via PKCa, ERK, or downstream kinases. It
is reported that ERK stabilizes GM-CSF mRNA in human
peripheral blood eosinophils although the target stabilizers
or destabilizers are unknown (Esnault and Malter, 2002).
PKCa is responsible for the binding of stabilizer protein HuR
to ARE of cyclooxygenase-2 mRNA (Subbaramaiah et al,
2003). Since HuR is known to stabilize GM-CSF mRNA (Fan
and Steitz, 1998), it may be involved in PKCa-mediated
stabilization of GM-CSF mRNA in histamine-stimulated
keratinocytes. Although Go¨6976 completely suppress his-
tamine-induced stabilization of GM-CSF mRNA, the inhibi-
tion by PD98059 was partial. This indicates that PKCa may
stabilize GM-CSF mRNA by both ERK-dependent and
-independent mechanisms, the latter of which may be the
phosphorylation of ARE-binding proteins by PKCa itself or
downstream kinases different from ERK. Further studies
should elucidate ARE-binding stabilizers or destabilizers
targeted by PKCa or ERK.
The level of endogenous histamine produced by kerati-
nocytes was less than threshold (0.1 mM) for GM-CSF
induction. More than threshold level of histamine in vivo
may be possibly derived from mast cells accumulated in
skin lesions with atopic dermatitis. Thus, our in vitro results
indicate that mast cell-derived histamine may contribute to
GM-CSF overproduction by keratinocytes in skin lesions
with atopic dermatitis. Since GM-CSF per se enhances
the production of c-Jun and c-Fos and promotes AP-1
transcriptional activity (Adunyah et al, 1991), keratinocyte-
derived GM-CSF may further promote its own transcription
via AP-1 and thus may perpetuate skin inflammation,
indicating positive feedback loop. In addition to atopic
dermatitis, GM-CSF is overproduced by keratinocytes
during tumor promotion or wounding (Braunstein et al,
1994; Robertson et al, 1994; Mann et al, 2001), and
degranulation of mast cells frequently occurs under these
conditions (Woolley et al, 1988; Artuc et al, 1999). Thus,
mast cell-derived histamine may also promote GM-CSF
production by keratinocytes in tumor promotion or wound-
ing. It should further be examined if topical application of
H1 antagonists may block GM-CSF production in murine
skin models of atopic dermatitis, tumor promotion, or
wounding.
Materials and Methods
Reagents Histamine dihydrochloride, cimetidine, pyrilamine, and
actinomycin D were obtained from Sigma (St Louis, Missouri).
Thioperamide maleate and SP600125 were purchased from
Biomol Research Laboratories Inc. (Plymouth Meeting, Pennsylva-
nia). GF109203X, Go¨6976, rottlerin, PD98059, and SB203580 were
obtained from Calbiochem (La Jolla, California). Antibodies used in
electrophoretic mobility shift assay (EMSA) were from Santa Cruz
Biotechnology (Santa Cruz, California).
Culture of keratinocytes Human neonatal foreskin keratinocytes
were cultured in serum-free KGM medium (Clonetics, Walkersville,
Maryland) consisting of basal medium MCDB153 supplemented
with 0.5 mg per mL hydrocortisone, 5 ng per mL epidermal growth
factor, 5 mg per mL insulin, and 0.5% bovine pituitary extract. The
cells in third passage were used.
GM-CSF secretion Keratinocytes (2  104 per well) were seeded
in triplicate into 24-well plates in 0.5 mL KGM, adhered overnight,
then the medium was changed to basal KBM depleted of growth
supplements, and incubated for 24 h. The medium was removed
and the cells were incubated with histamine in KBM for 24 h. The
supernatants were assayed for GM-CSF by ELISA (Biosource,
Camarillo, California). The sensitivity of the assay was 1 pg per mL.
RT-PCR Keratinocytes were incubated as above for 3 h, then total
cellular RNA was extracted using TRIzol reagent (Invitrogen,
Rockville, Maryland). We reverse transcribed 0.5 mg of total RNA
to produce cDNA as described (Tjandrawinata et al, 1997), and one
of 30 of synthesized cDNA was thermocycled for PCR amplifica-
tion with 1 mM each primer and 1.5 U of Taq polymerase
(Invitrogen). Primers for amplification and the sizes of respective
PCR products were as follows: GM-CSF, 50-TGGCTGCA-
GAGCCTGCTGCTC-30 and 50-CAGTTCCAGTGACTCTTTCGG-
TGGAGCGTC-30 for 432 bp.; glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), 50-GCAGGGGGGAGCCAAAAGGG-30
and 50-TGCCAGCCCCAGCGTCAAAG-30 for 566 bp (Pastore et
al, 1997; Kanda and Watanabe, 2002). PCR was performed by one
denaturing cycle of 951C for 3 min, 25 cycles of denaturation at
951C for 30 s, annealing at 581C for 30 s, and extension at 721C for
30 s, and a final extension at 721C for 3 min. In preliminary
experiments, 25 cycles lay in the exponential phase of amplifica-
tion for each gene examined. The PCR products were analyzed by
electrophoresis on 2.5% agarose gels and stained with ethidium
bromide, viewed by UV light. Densitometric analysis of the bands
was performed by NIH Image Software. The mRNA level of GM-
CSF was normalized to that of GAPDH.
mRNA stability analysis Keratinocytes were incubated with or
without histamine for 3 h. RNA synthesis was blocked by
actinomycin D (5 mg per mL), and total RNA was isolated 0, 30,
60, and 90 min later. RT-PCR was performed for GM-CSF and
GAPDH mRNA, as described in the previous section, and the
decay of mRNA was determined from band density ratios of GM-
CSF/GAPDH.
Plasmids and transfections The firefly luciferase reporter plas-
mids driven by human GM-CSF promoter (620/þ 37 bp relative
to the transcriptional start site) were constructed by PCR and
insertion into pGL3 basic vector (Promega) as described (Himes
et al, 1993), and was denoted as pGM-CSF luc. Site-specific
mutation of the promoter was created by multiple rounds of PCR
using primers with altered bases as described (Himes et al, 1993;
Jenkins et al, 1995; Pastore et al, 2000). p4xNF-kB-TATA-luc (NF-
kB, nuclear factor-kB) and p4xAP-1-TATA-luc were constructed by
inserting four copies of NF-kB (50-TTCAGGTAGTTCCCCCGC-30,
consensus sequence underlined) or activator protein-1 (AP-1) (50-
ACCATTAATCATTTC-30) from human GM-CSF promoter in front of
TATA box upstream of firefly luciferase reporter as described
(Kanda and Watanabe, 2003a). Transient transfections were
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performed with Effectene (Qiagen, Tokyo, Japan) as described
(Zellmer et al, 2001). The efficiency of transfection into keratino-
cytes by this method was mean  SEM 28.5%  3.1% (n¼ 9) as
determined by flow cytometry using b-galactosidase vector.
Keratinocytes were plated in 10-cm dishes and grown to about
60% confluence. Twenty-four hours before the transfection, the
medium was changed to KBM. Keratinocytes were incubated for 6
h with 5 mg of pGM-CSF luc or p4xNF-kB or AP-1-TATA-luc and 1
mg of herpes simplex virus thymidine kinase promoter-linked renilla
luciferase vector (pRL-TK), premixed with enhancer, transfection
buffer, and Effectene. The transfected cells were washed and
incubated in KBM for 18 h, then treated with histamine. After 6 h,
cell extracts were prepared and firefly and renilla luciferase
activities were quantified by dual luciferase assay system
(Promega). The results in each transfection were expressed as
ratios of firefly: renilla luciferase activities. In our preliminary
experiments, histamine did not alter the control renilla luciferase
activity (data not shown).
EMSA EMSA was performed as described (Jenkins et al, 1995).
The probes used were 32P-labelled annealed double-stranded
DNA containing NF-kB or AP-1 from human GM-CSF promoter.
The sequence of the NF-kB probe is 50-CCACAGTTCAGG-
TAGTTCCCCCGCCTCCCT-30 (consensus sequence underlined)
and that of AP-1 probe is 50-TGGTCACCATTAATCATTTCCTCT-
GT-30. For gel shift assays, 2–5 mg of nuclear protein extracts were
incubated at room temperature for 5 min with a mixture containing
6 mM HEPES (pH 7.9), 0.4 mM EDTA, 125 mM KCl, 10% glycerol,
0.05 mg per mL poly-dI-dC, 1 mM DTT, 2.5 mM sodium pyropho-
sphate, 1 mM b-glycerophosphate, 1 mM Na3VO4, 10 mM NaF,
50 mg per mL aprotinin, and 50 mg per mL leupeptin. One ng of
labeled probe was added and the reactions were incubated for
another 20 min. In antibody supershift experiments, the nuclear
extracts were preincubated with various antibodies for 30 min
before the addition of probe. Reactions were then fractionated on a
nondenaturing 5% polyacrylamide gel, and visualized with phos-
phorimager (Molecular Dynamics, Sunnyvale, California).
Western blot analysis Keratinocytes were incubated with 1 mM
histamine for indicated periods. The cells were lysed with lysis
buffer (50 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 1%
Triton X-100, 1.5 mM MgCl2, 100 mM NaF, 100 mM sodium
orthovanadate, and 1 mM EGTA (pH 7.7)) followed by centrifuga-
tion for 20 min at 14,000  g at 41C. Twenty mg of the supernatant
proteins were subjected to SDS-PAGE and transferred to a
nitrocellulose membrane. The membrane was blocked, and
incubated with anti-human inhibitory kBa (IkBa), phosphorylated
IkBa, c-Fos or c-Jun antibodies (Santa Cruz Biotechnology),
followed by peroxidase-conjugated secondary antibodies (Bio-
Rad, Hercules, California). The blots were developed with an
enhanced chemiluminescence kit (Amersham, Arlington Heights,
Illinois).
To detect the subcellular localization of PKC isoforms, cytosolic
and membrane fractions were obtained from whole-cell lysates.
Nuclei and debris were removed from the whole-cell lysates by
centrifugation (500  g, 5 min) and this post-nuclear fraction was
then centrifuged (105,000  g, 90 min). The supernatant was
saved as cytosolic fraction. The pellet was homogenized in the
same buffer, except for containing 0.1% Triton X-100. The samples
were mixed continuously for 1 h at 41C, then centrifuged as
described above. This supernatant was saved as membrane
fraction. Twenty mg proteins of the cytosolic or membrane fractions
were subjected to SDS-PAGE, transferred as above, and the blots
were incubated with anti-PKCa, d, e, Z, or z antibodies (Santa Cruz
Biotechnology), followed by secondary antibodies, and developed
as above.
Measurement of histamine release Keratinocytes (2  104 per
well) were seeded into 24-well plates in KGM, adhered overnight,
and incubated with KBM for 24 h. The medium was replaced with
fresh KBM, and the cells were incubated for 24 h. The histamine
concentration in the supernatant was measured by enzyme-linked
immunosorbent assay (Cosmo Bio, Tokyo, Japan).
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